Advertisement

Topics

AstraZeneca, Merck in $8.5B Oncology Pact

03:40 EDT 3 Aug 2017 | Contract Pharma

Will co-develop and co-commercialize Lynparza for multiple cancer types

Original Article: AstraZeneca, Merck in $8.5B Oncology Pact

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca, Merck in $8.5B Oncology Pact"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...